JPRN-UMIN000051978
Not yet recruiting
未知
A Multicenter Prospective Study of the Effect of Alcohol Consumption on Severity in Traffic Trauma Caused by Bicyclists - BIKE study
Tokyobay Urayasu Ichikawa Medical Center0 sites500 target enrollmentSeptember 1, 2023
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tokyobay Urayasu Ichikawa Medical Center
- Enrollment
- 500
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 1
A multicenter study on the effect of acupuncture at Siguan on delaying the progression of amnestic MCIamnestic mild cognitive impairmentITMCTR2100004551Xuanwu Hospital, Capital Medical University
Active, not recruiting
Not Applicable
Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: An international multicenter cohort studyKCT0008256Yonsei University Health System, Severance Hospital290
Recruiting
Not Applicable
A multicenter prospective study of the efficacy of prophylactic clip closure for prevention of delayed bleeding after colorectal ESD (endoscopic submucosal dissection)Colorectal neoplasmsJPRN-UMIN000036734Osaka University Graduate School of Medicine45
Recruiting
Not Applicable
A prospective multicenter study of the efficacy of pranlukast hydrate for infant patients with acute wheezing illness caused by RS virus infectioRepsratory Syncytial virus: RSVJPRN-UMIN000025608agoya University Hospital160
Active, not recruiting
Phase 1
The effects of Atrasentan on sperm production and the function of the testicles in male subjects with Type 1 or 2 Diabetes and NephropathyDiabetic NephropathyMedDRA version: 19.0Level: PTClassification code 10061835Term: Diabetic nephropathySystem Organ Class: 10038359 - Renal and urinary disordersTherapeutic area: Diseases [C] - Hormonal diseases [C19]EUCTR2016-000722-19-DEAbbVie Deutschland GmbH & Co. KG20